Skip to content

Lawyers Blame Popular Wrinkle Remover for 11 Injuries, 4 Deaths; Drugmaker Allergan Cites Long Safety Record

Botox Lawsuit Claims Drug Has Fatal Flaws

Botox: Government Concerns

The FDA announced in February its ongoing evaluation of reports of adverse reactions such as respiratory problems and death following the use of Botox and Myobloc for approved and unapproved uses. The review does not mean the FDA is advising physicians to discontinue use of the product or whether more regulatory action is needed, according to a statement on the FDA web site.

URAC: Accredited Health Web Site TRUSTe online privacy certification HONcode Seal AdChoices